SciVision Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	890.43	883.31	712.99	557.35	505.54	466.88
Revenue Growth (YoY)	7.11%	23.89%	27.93%	10.25%	8.28%	6.63%
Cost of Revenue	251.88	227.63	200.49	185.48	163.7	123.6
Gross Profit	638.55	655.68	512.49	371.87	341.84	343.28
Selling, General & Admin	357.47	346.86	259.44	184.8	153.95	136.87
Research & Development	80.86	60.71	53.42	52.46	65.94	59.78
Operating Expenses	438.33	407.57	312.86	237.26	219.89	196.64
Operating Income	200.22	248.11	199.64	134.61	121.94	146.64
Interest Expense	-6.26	-5.67	-8.22	-6.46	-8.07	-7.47
Interest & Investment Income	21.65	20.61	14.9	4.88	2.63	1.92
Currency Exchange Gain (Loss)	-23.9	20.48	-0.51	11.81	-1.46	-2.26
Other Non Operating Income (Expenses)	-6.7	1.43	0.75	0.17	1.01	9.31
EBT Excluding Unusual Items	185.01	284.96	206.56	145.02	116.05	148.13
Gain (Loss) on Sale of Investments	6.45	6.45	2.9	-1.98	-0.13	4.36
Gain (Loss) on Sale of Assets	-	0.19	0.54	30.55	0.13	-
Other Unusual Items	-	-	-	-0.04	-	-
Pretax Income	191.46	291.6	210	173.55	116.06	152.49
Income Tax Expense	26.74	49.34	32.1	31.83	14.34	24.48
Net Income	164.72	242.25	177.9	141.72	101.72	128.01
Net Income to Common	164.72	242.25	177.9	141.72	101.72	128.01
Net Income Growth	-23.75%	36.17%	25.53%	39.32%	-20.53%	6.05%
Shares Outstanding (Basic)	72	69	67	66	66	66
Shares Outstanding (Diluted)	74	74	76	75	71	71
Shares Change (YoY)	-2.22%	-2.58%	2.39%	5.18%	0.61%	0.70%
EPS (Basic)	2.29	3.51	2.66	2.14	1.54	1.93
EPS (Diluted)	2.24	3.30	2.41	1.92	1.51	1.89
EPS Growth	-23.43%	37.15%	25.26%	27.30%	-20.11%	5.88%
Free Cash Flow	145.99	235.11	257.28	167.03	72.73	59.63
Free Cash Flow Per Share	1.98	3.16	3.37	2.24	1.02	0.84
Dividend Per Share	3.250	3.250	2.500	2.000	1.420	0.885
Dividend Growth	30.00%	30.00%	25.00%	40.84%	60.49%	-25.88%
Gross Margin	71.71%	74.23%	71.88%	66.72%	67.62%	73.53%
Operating Margin	22.49%	28.09%	28.00%	24.15%	24.12%	31.41%
Profit Margin	18.50%	27.43%	24.95%	25.43%	20.12%	27.42%
Free Cash Flow Margin	16.39%	26.62%	36.08%	29.97%	14.39%	12.77%
EBITDA	267.19	310.17	261.42	195.35	173.08	160.23
EBITDA Margin	30.01%	35.12%	36.66%	35.05%	34.24%	34.32%
D&A For EBITDA	66.97	62.06	61.78	60.74	51.14	13.59
EBIT	200.22	248.11	199.64	134.61	121.94	146.64
EBIT Margin	22.48%	28.09%	28.00%	24.15%	24.12%	31.41%
Effective Tax Rate	13.96%	16.92%	15.29%	18.34%	12.35%	16.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.